🏅 FDA Orphan Designation
Harliku
nitisinone
Manufacturer: Cycle Pharmaceuticals Ltd.
Indicated for:
AlkaptonuriaOrphan
FDA-Approved Indications (1)
AlkaptonuriaOrphan Designation
reduction of urine homogentisic acid (HGA) in adult patients with alkaptonuria (AKU)
Indications & Usage
1 INDICATIONS AND USAGE HARLIKU TM is indicated for the reduction of urine homogentisic acid (HGA) in adult patients with alkaptonuria (AKU). HARLIKU is a hydroxyphenyl-pyruvate dioxygenase inhibitor indicated for the reduction of urine homogentisic acid (HGA) in adult patients with alkaptonuria (AKU). ( 1 )
💙 Support Programs
View all →Harliku
Cycle Pharmaceuticals Ltd.
Where shown, WAC (Wholesale Acquisition Cost) is an estimate only — your actual cost depends on your insurance plan. Always verify pricing with your pharmacy or insurer.
Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.